{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:19:25Z","timestamp":1767676765042},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2011,9,28]],"date-time":"2011-09-28T00:00:00Z","timestamp":1317168000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s11010-011-1082-0","type":"journal-article","created":{"date-parts":[[2011,9,27]],"date-time":"2011-09-27T06:14:46Z","timestamp":1317104086000},"page":"19-29","source":"Crossref","is-referenced-by-count":13,"title":["EGFR- and AKT-mediated reduction in PTEN expression contributes to tyrphostin resistance and is reversed by mTOR inhibition in endometrial cancer cells"],"prefix":"10.1007","volume":"361","author":[{"given":"Tian","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuebo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengfang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lirong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,28]]},"reference":[{"key":"1082_CR1","doi-asserted-by":"crossref","first-page":"984013","DOI":"10.1155\/2010\/984013","volume":"2010","author":"T Okuda","year":"2010","unstructured":"Okuda T, Sekizawa A, Purwosunu Y, Nagatsuka M, Morioka M, Hayashi M, Okai T (2010) Genetics of endometrial cancers. Obstet Gynecol Int 2010:984013","journal-title":"Obstet Gynecol Int"},{"key":"1082_CR2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jsbmb.2007.09.020","volume":"108","author":"A Doll","year":"2008","unstructured":"Doll A, Abal M, Rigau M, Monge M, Gonzalez M, Demajo S, Colas E, Llaurado M, Alazzouzi H, Planaguma J, Lohmann MA, Garcia J, Castellvi S, Ramon YCJ, Gil-Moreno A, Xercavins J, Alameda F, Reventos J (2008) Novel molecular profiles of endometrial cancer-new light through old windows. J Steroid Biochem Mol Biol 108:221\u2013229","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1082_CR3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijrobp.2003.10.027","volume":"59","author":"RS Herbst","year":"2004","unstructured":"Herbst RS (2004) Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys 59:21\u201326","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1082_CR4","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1158\/1078-0432.CCR-08-0905","volume":"15","author":"P Laurent-Puig","year":"2009","unstructured":"Laurent-Puig P, Lievre A, Blons H (2009) Mutations and response to epidermal growth factor receptor inhibitors. Clin Cancer Res 15:1133\u20131139","journal-title":"Clin Cancer Res"},{"key":"1082_CR5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2174\/156800906777441799","volume":"6","author":"HS Chon","year":"2006","unstructured":"Chon HS, Hu W, Kavanagh JJ (2006) Targeted therapies in gynecologic cancers. Curr Cancer Drug Targets 6:333\u2013363","journal-title":"Curr Cancer Drug Targets"},{"key":"1082_CR6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/107327480901600102","volume":"16","author":"N Bansal","year":"2009","unstructured":"Bansal N, Yendluri V, Wenham RM (2009) The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies. Cancer Control 16:8\u201313","journal-title":"Cancer Control"},{"key":"1082_CR7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/00313020601153273","volume":"39","author":"AN Cheung","year":"2007","unstructured":"Cheung AN (2007) Molecular targets in gynaecological cancers. Pathology 39:26\u201345","journal-title":"Pathology"},{"key":"1082_CR8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/09513590801953556","volume":"24","author":"A Gadducci","year":"2008","unstructured":"Gadducci A, Tana R, Cosio S, Fanucchi A, Genazzani AR (2008) Molecular target therapies in endometrial cancer: from the basic research to the clinic. Gynecol Endocrinol 24:239\u2013249","journal-title":"Gynecol Endocrinol"},{"key":"1082_CR9","first-page":"4340","volume":"9","author":"QB She","year":"2003","unstructured":"She QB, Solit D, Basso A, Moasser MM (2003) Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3\u2032-kinase\/AKT pathway signaling. Clin Cancer Res 9:4340\u20134346","journal-title":"Clin Cancer Res"},{"key":"1082_CR10","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1677\/erc.1.00986","volume":"12","author":"C Festuccia","year":"2005","unstructured":"Festuccia C, Muzi P, Millimaggi D, Biordi L, Gravina GL, Speca S, Angelucci A, Dolo V, Vicentini C, Bologna M (2005) Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines. Endocr Relat Cancer 12:983\u2013998","journal-title":"Endocr Relat Cancer"},{"key":"1082_CR11","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0002-9440(10)64656-1","volume":"158","author":"GL Mutter","year":"2001","unstructured":"Mutter GL (2001) PTEN, a protean tumor suppressor. Am J Pathol 158:1895\u20131898","journal-title":"Am J Pathol"},{"key":"1082_CR12","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/jnci\/92.11.924","volume":"92","author":"GL Mutter","year":"2000","unstructured":"Mutter GL, Lin MC, Fitzgerald JT, Kum JB, Baak JP, Lees JA, Weng LP, Eng C (2000) Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst 92:924\u2013930","journal-title":"J Natl Cancer Inst"},{"key":"1082_CR13","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00441-005-0082-3","volume":"323","author":"K Uegaki","year":"2006","unstructured":"Uegaki K, Kanamori Y, Kigawa J, Kawaguchi W, Kaneko R, Naniwa J, Takahashi M, Shimada M, Oishi T, Itamochi H, Terakawa N (2006) PTEN is involved in the signal transduction pathway of contact inhibition in endometrial cells. Cell Tissue Res 323:523\u2013528","journal-title":"Cell Tissue Res"},{"key":"1082_CR14","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/annonc\/mdh388","volume":"15","author":"LA DeGraffenried","year":"2004","unstructured":"DeGraffenried LA, Fulcher L, Friedrichs WE, Grunwald V, Ray RB, Hidalgo M (2004) Reduced PTEN expression in breast cancer cells confers susceptibility to inhibitors of the PI3 kinase\/AKT pathway. Ann Oncol 15:1510\u20131516","journal-title":"Ann Oncol"},{"key":"1082_CR15","doi-asserted-by":"crossref","first-page":"10314","DOI":"10.1073\/pnas.171076798","volume":"98","author":"MS Neshat","year":"2001","unstructured":"Neshat MS, Mellinghoff IK, Tran C, Stiles B, Thomas G, Petersen R, Frost P, Gibbons JJ, Wu H, Sawyers CL (2001) Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP\/mTOR. Proc Natl Acad Sci USA 98:10314\u201310319","journal-title":"Proc Natl Acad Sci USA"},{"key":"1082_CR16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ygyno.2007.03.006","volume":"106","author":"L Albitar","year":"2007","unstructured":"Albitar L, Carter MB, Davies S, Leslie KK (2007) Consequences of the loss of p53, RB1, and PTEN: relationship to gefitinib resistance in endometrial cancer. Gynecol Oncol 106:94\u2013104","journal-title":"Gynecol Oncol"},{"key":"1082_CR17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2174\/156800906777441799","volume":"6","author":"HS Chon","year":"2006","unstructured":"Chon HS, Hu W, Kavanagh JJ (2006) Targeted therapies in gynecologic cancers. Curr Cancer Drug Targets 6:333\u2013363","journal-title":"Curr Cancer Drug Targets"},{"key":"1082_CR18","doi-asserted-by":"crossref","first-page":"7864","DOI":"10.1158\/0008-5472.CAN-04-4392","volume":"66","author":"MY Wang","year":"2006","unstructured":"Wang MY, Lu KV, Zhu S, Dia EQ, Vivanco I, Shackleford GM, Cavenee WK, Mellinghoff IK, Cloughesy TF, Sawyers CL, Mischel PS (2006) Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells. Cancer Res 66:7864\u20137869","journal-title":"Cancer Res"},{"key":"1082_CR19","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1200\/JCO.2007.15.8808","volume":"26","author":"AM Oza","year":"2008","unstructured":"Oza AM, Eisenhauer EA, Elit L, Cutz JC, Sakurada A, Tsao MS, Hoskins PJ, Biagi J, Ghatage P, Mazurka J, Provencher D, Dore N, Dancey J, Fyles A (2008) Phase II study of erlotinib in recurrent or metastatic endometrial cancer: NCIC IND-148. J Clin Oncol 26:4319\u20134325","journal-title":"J Clin Oncol"},{"key":"1082_CR20","first-page":"855","volume":"15","author":"LL Tang","year":"2006","unstructured":"Tang LL, Yokoyama Y, Wan X, Iwagaki S, Niwa K, Tamaya T (2006) PTEN sensitizes epidermal growth factor-mediated proliferation in endometrial carcinoma cells. Oncol Rep 15:855\u2013859","journal-title":"Oncol Rep"},{"key":"1082_CR21","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00432-009-0756-4","volume":"136","author":"L Xiao","year":"2010","unstructured":"Xiao L, Yang YB, Li XM, Xu CF, Li T, Wang XY (2010) Differential sensitivity of human endometrial carcinoma cells with different PTEN expression to mitogen-activated protein kinase signaling inhibits and implications for therapy. J Cancer Res Clin Oncol 136:1089\u20131099","journal-title":"J Cancer Res Clin Oncol"},{"key":"1082_CR22","first-page":"681","volume":"44","author":"L Xiao","year":"2009","unstructured":"Xiao L, Yang YB, Shen HM, Xu CF, Wang XY, Li XM (2009) Effect of signal transduction inhibitors on human endometrial carcinoma cells with differential PTEN gene expression. Zhonghua Fu Chan Ke Za Zhi 44:681\u2013685","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"1082_CR23","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/sj.cdd.4400982","volume":"9","author":"X Wan","year":"2002","unstructured":"Wan X, Yokoyama Y, Shinohara A, Takahashi Y, Tamaya T (2002) PTEN augments staurosporine-induced apoptosis in PTEN-null Ishikawa cells by downregulating PI3K\/AKT signaling pathway. Cell Death Differ 9:414\u2013420","journal-title":"Cell Death Differ"},{"key":"1082_CR24","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1525-1438.2007.00890.x","volume":"17","author":"X Wan","year":"2007","unstructured":"Wan X, Li J, Xie X, Lu W (2007) PTEN augments doxorubicin-induced apoptosis in PTEN-null Ishikawa cells. Int J Gynecol Cancer 17:808\u2013812","journal-title":"Int J Gynecol Cancer"},{"key":"1082_CR25","first-page":"1170","volume":"123","author":"LJ Zhao","year":"2010","unstructured":"Zhao LJ, Liu N, Li XP, Wang JL, Wei LH (2010) Phosphatase and tensin homolog gene inhibits the effect induced by gonadotropin-releasing hormone subtypes in human endometrial carcinoma cells. Chin Med J (Engl) 123:1170\u20131175","journal-title":"Chin Med J (Engl)"},{"key":"1082_CR26","first-page":"1069","volume":"15","author":"A Sakurada","year":"1999","unstructured":"Sakurada A, Hamada H, Fukushige S, Yokoyama T, Yoshinaga K, Furukawa T, Sato S, Yajima A, Sato M, Fujimura S, Horii A (1999) Adenovirus-mediated delivery of the PTEN gene inhibits cell growth by induction of apoptosis in endometrial cancer. Int J Oncol 15:1069\u20131074","journal-title":"Int J Oncol"},{"key":"1082_CR27","doi-asserted-by":"crossref","first-page":"7639","DOI":"10.1158\/0008-5472.CAN-06-0419","volume":"66","author":"HG Wendel","year":"2006","unstructured":"Wendel HG, Malina A, Zhao Z, Zender L, Kogan SC, Cordon-Cardo C, Pelletier J, Lowe SW (2006) Determinants of sensitivity and resistance to rapamycin-chemotherapy drug combinations in vivo. Cancer Res 66:7639\u20137646","journal-title":"Cancer Res"},{"key":"1082_CR28","doi-asserted-by":"crossref","first-page":"10314","DOI":"10.1073\/pnas.171076798","volume":"98","author":"MS Neshat","year":"2001","unstructured":"Neshat MS, Mellinghoff IK, Tran C, Stiles B, Thomas G, Petersen R, Frost P, Gibbons JJ, Wu H, Sawyers CL (2001) Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP\/mTOR. Proc Natl Acad Sci USA 98:10314\u201310319","journal-title":"Proc Natl Acad Sci USA"},{"key":"1082_CR29","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00432-008-0529-5","volume":"135","author":"S Darb-Esfahani","year":"2009","unstructured":"Darb-Esfahani S, Faggad A, Noske A, Weichert W, Buckendahl AC, Muller B, Budczies J, Roske A, Dietel M, Denkert C (2009) Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro. J Cancer Res Clin Oncol 135:933\u2013941","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-011-1082-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-011-1082-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-011-1082-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,16]],"date-time":"2019-06-16T14:24:52Z","timestamp":1560695092000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-011-1082-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,28]]},"references-count":29,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["1082"],"URL":"https:\/\/doi.org\/10.1007\/s11010-011-1082-0","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,28]]}}}